Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
Start free trial
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
Special Offer: Just $199
×
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
These 3 Apparel Stocks Are Fit for a Comeback
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
These 3 Apparel Stocks Are Fit for a Comeback
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
These 3 Apparel Stocks Are Fit for a Comeback
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
These 3 Apparel Stocks Are Fit for a Comeback
TSE:FRX

Fennec Pharmaceuticals - FRX Stock Forecast, Price & News

C$12.94
+0.14 (+1.09%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
C$12.87
▼
C$13.15
50-Day Range
C$9.94
▼
C$12.94
52-Week Range
C$4.95
▼
C$13.15
Volume
1,300 shs
Average Volume
1,364 shs
Market Capitalization
C$339.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$10.00

Fennec Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
22.7% Downside
C$10.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of Fennec Pharmaceuticals in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
C$250,942 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.80 out of 5 stars

See Top Rated MarketRank™ Stocks Here
FRX stock logo

About Fennec Pharmaceuticals (TSE:FRX) Stock

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

FRX Stock News Headlines

November 26, 2022 | americanbankingnews.com
FY2022 EPS Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX) Lowered by Cantor Fitzgerald
November 23, 2022 | americanbankingnews.com
Fennec Pharmaceuticals (TSE:FRX) Upgraded to "Overweight" at Cantor Fitzgerald
November 11, 2022 | finanznachrichten.de
Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
November 11, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
November 1, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Are Analysts Optimistic?
October 17, 2022 | nasdaq.com
Fennec Pharma Announces Availability Of PEDMARK - Quick Facts
October 17, 2022 | technews.tmcnet.com
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
October 17, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
September 21, 2022 | ca.finance.yahoo.com
Stocks in play: Fennec Pharmaceuticals Inc
September 21, 2022 | finance.yahoo.com
RTP pharma to see $20M infusion on heels of drug winning approval
August 12, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update
August 1, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
July 10, 2022 | finance.yahoo.com
What Kind Of Shareholders Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC)?
February 28, 2022 | finance.yahoo.com
Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update
November 29, 2021 | finance.yahoo.com
Fennec Pharmaceuticals Expects FDA Rejection for New Drug
November 29, 2021 | finance.yahoo.com
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
August 2, 2021 | finance.yahoo.com
Is Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Popular Amongst Institutions?
June 22, 2021 | ca.finance.yahoo.com
Stocks in play: Fennec Pharmaceuticals Inc.
June 22, 2021 | finance.yahoo.com
Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity
May 28, 2021 | finance.yahoo.com
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK™
May 13, 2021 | finance.yahoo.com
Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
February 2, 2021 | msn.com
Rocket League's Fennec finally has esports decals
January 26, 2021 | msn.com
Rocket League update coming on Feb. 1, introducing new esports items
December 3, 2020 | finance.yahoo.com
Here is What Hedge Funds Think About Fennec Pharmaceuticals Inc. (FENC)
November 19, 2020 | finance.yahoo.com
New Strong Sell Stocks for November 19th
See More Headlines
Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

FRX Company Calendar

Today
11/29/2022
Next Earnings (Estimated)
2/27/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:FRX
CUSIP
N/A
CIK
N/A
Web
fennecpharma.com
Phone
+1-919-6364530
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$10.00
High Stock Price Forecast
C$10.00
Low Stock Price Forecast
C$10.00
Forecasted Upside/Downside
-22.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
881.09
Current Ratio
10.30
Quick Ratio
10.17

Sales & Book Value

Annual Sales
C$170,000.00
Price / Sales
1,997.17
Cash Flow
C$1.27 per share
Price / Cash Flow
10.19
Book Value
C$0.11 per share
Price / Book
120.93

Miscellaneous

Outstanding Shares
26,238,000
Free Float
N/A
Market Cap
C$339.52 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Rostislav Raykov (Age 46)
    CEO & Director
    Comp: $468.45k
  • Mr. Robert C. Andrade (Age 47)
    Chief Financial Officer
    Comp: $339.41k
  • Mr. Mark Meier
    Sr. VP of Commercial
  • Mr. Mark Gowland
    Controller
  • Mr. Lei Fang
    Pres of Pharstat Inc
  • Ms. Anne McKay (Age 68)
    Regulatory Consultant
  • Mr. Alexander D. Smith M.S.
    Consultant

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













FRX Stock - Frequently Asked Questions

Should I buy or sell Fennec Pharmaceuticals stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fennec Pharmaceuticals in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FRX shares.
View FRX analyst ratings or view top-rated stocks.

What is Fennec Pharmaceuticals' stock price forecast for 2023?

5 equities research analysts have issued 1 year target prices for Fennec Pharmaceuticals' stock. Their FRX share price forecasts range from C$10.00 to C$10.00. On average, they predict the company's stock price to reach C$10.00 in the next twelve months. This suggests that the stock has a possible downside of 22.7%.
View analysts price targets for FRX or view top-rated stocks among Wall Street analysts.

How have FRX shares performed in 2022?

Fennec Pharmaceuticals' stock was trading at C$5.60 at the beginning of the year. Since then, FRX stock has increased by 131.1% and is now trading at C$12.94.
View the best growth stocks for 2022 here.

When is Fennec Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our FRX earnings forecast.

What other stocks do shareholders of Fennec Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fennec Pharmaceuticals investors own include Encanto Potash (EPO), Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB), Air Canada (AC) and Barrick Gold (ABX).

What is Fennec Pharmaceuticals' stock symbol?

Fennec Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "FRX."

How do I buy shares of Fennec Pharmaceuticals?

Shares of FRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Fennec Pharmaceuticals' stock price today?

One share of FRX stock can currently be purchased for approximately C$12.94.

How much money does Fennec Pharmaceuticals make?

Fennec Pharmaceuticals (TSE:FRX) has a market capitalization of C$339.52 million and generates C$170,000.00 in revenue each year.

How can I contact Fennec Pharmaceuticals?

Fennec Pharmaceuticals' mailing address is 68 Tw Alexander Dr PO Box 13628, DURHAM, NC 27709-3628, United States. The official website for the company is fennecpharma.com. The biopharmaceutical company can be reached via phone at +1-919-6364530.

This page (TSE:FRX) was last updated on 11/29/2022 by MarketBeat.com Staff